A carregar...
New diarylsulfonamide inhibitors of Leishmania infantum amastigotes
New drugs against visceral leishmaniasis with mechanisms of action differing from existing treatments and with adequate cost, stability, and properties are urgently needed. No antitubulin drug is currently in the clinic against Leishmania infantum, the causative agent of visceral leishmaniasis in th...
Na minha lista:
| Publicado no: | Int J Parasitol Drugs Drug Resist |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8142021/ https://ncbi.nlm.nih.gov/pubmed/34015753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2021.02.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|